亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

5-硝基-2-氟苯甲酸 7304-32-7

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 江西吉安市付款后3天內(nèi)
型號(hào) 7304-32-7
規(guī)格 98.0%min
過期 長(zhǎng)期有效
更新 2011-03-02 20:25
 

江西三豐精細(xì)化工有限公司

企業(yè)會(huì)員第15年
資料未認(rèn)證
保證金未繳納
  • 江西-吉安市
  • 上次登錄 2013-12-09
  • 三豐化工 (先生)   銷售經(jīng)理
詳細(xì)說明

As a faithful manufacturer and exporter,we are deeply honoured to supply the following products. If you need any, please don't hesitate to contact with us,thank you!

Jiangxi Sanpharm Fine Chemical Co., Ltd.
Add: South Industrial Park, Yongfeng County, Jiangxi Province, China
Tel:+86-796-2218118   Fax:+86-796-2218128
Email:sanpharm@yeah.net MSN:sanpharma@hotmail.com
Website:www.sfpharm.com

Products List
1. Advanced Pharmaceuticals
No. Product Name                              CAS No.     Specification
1. Acebrophylline                               96989-76-3   99.0%min
2. Acefylline;7H-Purine-7-acetic acid  652-37-9      99.0%min
3. Butaphosphan;Butafosfan             17316-67-5   99.0%min
4. Imatinib mesylate                           220127-57-1 99.0%min
5. Imatinib base                                152459-95-5   99.0%min
6. Meta-Methoxysynephrine Hcl       150961-17-0   99.0%min
7. Tetradecylthioacetic acid;TTA       2921-20-2     98.5%min
8. Methyl-Tetradecylthioacetic acid;   214491-16-4  98.5%min
9. (R)-Xanthoanthrafil                        247568-68-9   98.5%min
10.Xanthoanthrafil                             1020251-53-9  98.5%min
11.1,3-N-Dipropyl-7-Propargylxanthine 102284-70-8   98.5%min

2. Intermediates & Special Chemicals
No. Product Name                                                    CAS No.     Specification
1.  AZO initiator VA-061;2,2'-Azobis[2-(2-imidazolin-2-yl)propane]  20858-12-2  98.0%min
2.  AZO initiator VA-086;2,2'-Azobis[2-methyl-N-(2-hydroxy ethyl)propinamide] 61551-69-7 98.0%min
3.  Guanazole sulfate;3,5-Diamino-1,2,4-triazole Sulfate (2:1)      92278-55-2  99.0%min
4.  Guanazole;3,5-Diamino-1,2,4-triazole                    1455-77-2   98.0%min
5.  Noreleagnine;1,2,3,4-tetrahydro-Beta-carboline    16502-01-5  98.0%min
6.  Diphenylphosphinic acid                                         1707-03-5   98.0%min
7.  2-nitroimidazole                                                       527-73-1    98.0%min
8.  5-nitro-2-fluoro-benzoic acid                                   7304-32-7   98.0%min
9.  N-ethyl-2-methyl; 2-Propanamine                            4432-77-3   75.0%min
10-1. N,N-Dimethyl-3-(2-thienyl)-3-hydroxypro-panamine               13636-02-7  98.0%min
10-2. (s)-(-)-N,N-dimethyl-3-hydroxy-3-(2-thienyl)-propanamine      132335-44-5 98.0%min
11-1. 4-(4-Methylpiperazin-1-ylmethyl)benzoic acid dihydrochloride 106261-49-8 98.0%min
11-2. N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine 152460-10-1 98.0%min
11-3. N-(5-nitro-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine   152460-09-8 98.0%min
12. 2-Hydroxyphenylacetic acid                                    614-75-5    98.0%min
13. 2,3-Dichloropyridine                                               2402-77-9   99.0%min

舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
Octopamine hcl Synephrine Hcl 布他磷;Butaphosphan;Butafosfan 伊馬替尼 中間體 Xanthoanthrafil (R)-Xanthoanthrafil 2-硝基咪唑 527-73-1
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |